ArticleInternational journal of clinical pharmacy2022
Predicting adverse drug events in older inpatients: a machine learning study.
Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Machine learning to predict adverse drug events based on electronic health records: a systematic review and meta-analysis.The Journal of international medical research · 2024Pooled it
- Using machine learning or deep learning models in a hospital setting to detect inappropriate prescriptions: a systematic review.European journal of hospital pharmacy : science and practice · 2024Pooled it
- Machine learning risk prediction models for medication harm in hospitalised adult patients.Therapeutic advances in drug safety · 2026Article
- Artificial intelligence-driven risk prediction of polypharmacy in older adults: current advances, clinical applications, and future perspectives.Frontiers in public health · 2026Review
- Analytical approaches for medication management for patient safety: a scoping review.npj health systems · 2025Article
- Artificial Intelligence in Medication Management for Older Adults in Low- and Middle-Income Countries: A Narrative Review.Aging medicine (Milton (N.S.W)) · 2025Review
- Artificial intelligence in pharmacovigilance: a narrative review and practical experience with an expert-defined Bayesian network tool.International journal of clinical pharmacy · 2025Review
- The tree-based pipeline optimization tool: Tackling biomedical research problems with genetic programming and automated machine learning.Patterns (New York, N.Y.) · 2025Article
- Towards a prescribing monitoring system for medication safety evaluation within electronic health records: a scoping review.BMC medical informatics and decision making · 2025Article
- Machine learning based on nutritional assessment to predict adverse events in older inpatients with possible sarcopenia.Aging clinical and experimental research · 2025Article
- A model for identifying potentially inappropriate medication used in older people with dementia: a machine learning study.International journal of clinical pharmacy · 2024Article
- Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method.Frontiers in pharmacology · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundBuilding an effective prediction model of adverse drug events (ADE) is necessary to prevent harm caused by medication in older inpatients.
aimThis study aimed to develop a machine learning-based prediction model for the prediction of ADE and explore the risk factors associated with ADEs in older inpatients.
methodData were from an observational, retrospective study that included 1800 older Chinese inpatients. After dividing the patients into training and test sets (8:2), seven machine learning models were used. Demographic, admission, and treatment clinical variables were considered for model development. The discriminative performance of the model by the area under the receiver operating characteristic curve (ROC) was evaluated. We also calculated the model's accuracy, precision, recall, and F1 scores.
resultsAmong 1800 patients, 296 ADEs were detected in 234 (13.00%) patients. The main cause of ADEs was antineoplastic agents (55.74%). Seven algorithms, including eXtreme Gradient Boosting (XGBoost), AdaBoost, CatBoost, Gradient Boosting Decision Tree (GBDT), Light Gradient Boosting Machine (LightGBM), Tree-based Pipeline Optimization Tool (TPOT) and Random Forest (RF), were used to establish the prediction model. The Adaboost model was chosen with the best predictive ability (accuracy 88.06%, precision 68.57%, recall 48.21%, F1 52.75%, and AUC 0.91). Ten significant factors associated with ADEs were identified, including the number of true triggers (+), length of stay, doses per patient, age, number of admissions in the previous year, surgery, drugs per patient, number of medical diagnoses, antibacterial use, and gender.
conclusionUsing machine learning, this novel study establishes an ADE prediction model in older patients. The sophisticated computer algorithm can be implemented at the bedside to improve patient safety in clinical practice.
Indexed as
Identifiers
36115909What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.